Document is current
Any future updates will be listed below
-
Authors
Zaanan, Aziz https://orcid.org/0000-0001-8372-5653
Didelot, Audrey
Broudin, Chloé https://orcid.org/0000-0002-0696-3364
Laliotis, George https://orcid.org/0000-0001-9205-8258
Spickard, Erik https://orcid.org/0000-0002-5024-3559
Dutta, Punashi
Saltel-Fulero, Aurélien
Sullo, Francesco Giulio https://orcid.org/0000-0002-6478-0638
Pizzamiglio, Margot
Mariani, Antoine
Lahlou, Widad
Malhotra, Meenakshi
Sharma, Shruti
Sethi, Himanshu
Jurdi, Adham https://orcid.org/0000-0002-2985-3053
Liu, Minetta C. https://orcid.org/0000-0002-8206-5232
Laurent-Puig, Pierre https://orcid.org/0000-0001-8475-5459
- License Information
-
More Information
Article History
Received: 22 November 2024
Accepted: 4 July 2025
First Online: 24 July 2025
Competing interests
: All authors have disclosed relevant conflicts of interest. G.L., E.S., P.D., M.M., S.S., H.S., A.J., and M.C.L. are employees of Natera, Inc. and have stock/option to hold stock in the company. Additional COIs for M.C.L.: Grants/Contracts: Funding to Institution (Mayo) from: Eisai, Exact Sciences, Genentech, Genomic Health, GRAIL, Menarini Silicon Biosystems, Merck, Novartis, Seattle Genetics, Tesaro; Travel Support Reimbursement from AstraZeneca, Genomic Health, Ionis; Ad hoc advisory board meetings. All funds to Mayo Clinic. No personal compensation from AstraZeneca, Celgene, Roche/Genentech, Genomic Health, GRAIL, Ionis, Merck, Pfizer, Seattle Genetics, Syndax. A.Z. has participated in consulting and/or advisory boards for Amgen, Astellas, Merck, Roche, Servier, MSD, BMS, Pierre Fabre, Daiichi Sankyo, Astra Zeneca, Bayer, BeiGene, Astra Zeneca, Gilead, Abbvie. P.L.P. is the founder and shareholder of MethysDx, and a member of advisory board of Biocartis, Amgen, BMS, Pierre Fabre.
